Characterization and Phase I Study of CLR457, an Orally Bioavailable Pan-Class I PI3-kinase Inhibitor
Investigational New Drugs（2018）
Key words
CLR457,Pan-PI3K inhibitor,Therapeutic index,Phase I,Preclinical
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined